Life Sciences Alternative Funding LLC 13D and 13G filings for Biodesix, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-13 07:30 am Sale | 2024-09-30 | 13G | Biodesix, Inc. BDSX | Life Sciences Alternative Funding LLC | 2,180,514 1.500% | -9,913 (-0.45%) | Filing |
| 2021-05-28 6:03 pm Purchase | 2020-12-31 | 13G | Biodesix, Inc. BDSX | Life Sciences Alternative Funding LLC | 2,190,427 8.200% | 2,190,427 (New Position) | Filing |